GMAB
Genmab·NASDAQ
--
--(--)
--
--(--)
GMAB fundamentals
Genmab (GMAB) released its earnings on Feb 17, 2026: revenue was 1.06B (YoY +18.22%), beat estimates; EPS was 0.4715 (YoY -44.59%), beat estimates.
Revenue / YoY
1.06B
+18.22%
EPS / YoY
0.4715
-44.59%
Report date
Feb 17, 2026
EPS
Revenue
Revenue & Expenses
GMAB has released its 2025 Q3 earnings report, with revenue of 1.02B, reflecting a YoY change of 25.25%, and net profit of 401.00M, showing a YoY change of 115.59%. The Sankey diagram below clearly presents GMAB's revenue sources and cost distribution.
Key Indicators
Genmab (GMAB) key financial stats and ratios, covering profitability, financial health, and leverage.
Genmab (GMAB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Genmab (GMAB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Genmab (GMAB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Genmab (GMAB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Genmab (GMAB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Genmab next quarter?What is Genmab's gross profit margin?What factors drove the changes in Genmab's revenue and profit?What does Genmab do and what are its main business segments?What is Genmab's latest dividend and current dividend yield?What were the key takeaways from Genmab's earnings call?What is the revenue and EPS growth rate for Genmab year over year?What were the key takeaways from Genmab’s earnings call?
